Dr. Jianjun Zhang 张剑军
Chief Physician
Department of Gastric Surgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive cancer care with a focus on surgery.
Dr. Zhang holds a doctorate in surgical oncology and serves as a master’s supervisor. The doctor has published multiple academic reports and received the Liaoning Provincial Science and Technology Achievement Award and the Liaoning Provincial Science and Technology Progress Award.
Professional roles
- Member, Accelerated Recovery Group, Gastric Cancer Professional Committee, China Anti-Cancer Association
- Member, Gastrointestinal Stromal Tumor Professional Committee, China Anti-Cancer Association
- Standing Committee Member, Gastric Cancer Professional Committee, Liaoning Anti-Cancer Association
- Vice Chair, MDT Professional Committee, Liaoning Society for Cell Biology
Name order: in Chinese the family name comes first (Zhang Jianjun). Papers usually list the name as Jianjun Zhang or Zhang J.
Selected publications
29 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cell Death Discov, 2026 (senior author): MFAP2 secreted by TGF-β1-induced cancer-associated fibroblast cells promotes gastric cancer peritoneal metastasis through Src-STAT3-PTK7 axis. PubMed 42420251
- J Biomed Inform, 2023 (senior author): An omics data analysis method based on feature linear relationship and graph convolutional network. PubMed 37634557
- Front Oncol, 2022 (senior author): Predictive value of NLR and PLR in response to preoperative chemotherapy and prognosis in locally advanced gastric cancer. PubMed 36110962
- BMC Cancer, 2022 (senior author): LMOD1, an oncogene associated with Lauren classification, regulates the metastasis of gastric cancer cells through the FAK-AKT/mTOR pathway. PubMed 35488236
- J Cancer, 2021 (senior author): CA724 Predicts Tumor Regression Grade in Locally Advanced Gastric Cancer Patients with Neoadjuvant Chemotherapy. PubMed 34659537
- Med Sci Monit, 2021 (senior author): Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer. PubMed 33758160
- BMC Cancer, 2021 (senior author): CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy. PubMed 33402124
- Cancer Res Treat, 2021 (senior author): Evaluation and Comparison of Predictive Value of Tumor Regression Grades according to Mandard and Becker in Locally Advanced Gastric Adenocarcinoma. PubMed 32777876
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion